ABSTRACT

Now that prohibitions against stem cell research are relaxing, it is time for the field to move forward with the advances that promise to eliminate so much human suffering. However, it would be naive to ignore the fact that regenerative medicines pose a whole new set of challenges to an industry sector that for decades has geared itself to the deve

part |2 pages

SECTION 1 Introduction

chapter 1|6 pages

What Is Regenerative Medicine?

part |2 pages

SECTION 3 Business Models

part |2 pages

SECTION 5 Regulatory Landscape

part |2 pages

SECTION 7 Insurance and Risk Management